BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30987615)

  • 21. MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.
    Wang H; Zhang G; Wu Z; Lu B; Yuan D; Li X; Lu Z
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C216-21. PubMed ID: 26506880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.
    Ganci F; Pulito C; Valsoni S; Sacconi A; Turco C; Vahabi M; Manciocco V; Mazza EMC; Meens J; Karamboulas C; Nichols AC; Covello R; Pellini R; Spriano G; Sanguineti G; Muti P; Bicciato S; Ailles L; Strano S; Fontemaggi G; Blandino G
    Clin Cancer Res; 2020 Jun; 26(12):2956-2971. PubMed ID: 31969334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc.
    Prensner JR; Chen W; Han S; Iyer MK; Cao Q; Kothari V; Evans JR; Knudsen KE; Paulsen MT; Ljungman M; Lawrence TS; Chinnaiyan AM; Feng FY
    Neoplasia; 2014 Nov; 16(11):900-8. PubMed ID: 25425964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
    Wang S; Chen X; Qiao T
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
    Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
    Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.
    Gou C; Han P; Li J; Gao L; Ji X; Dong F; Su Q; Zhang Y; Liu X
    Br J Radiol; 2020 Apr; 93(1108):20190154. PubMed ID: 31944856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA FAM239A promotes tumor cell proliferation and migration by regulating tyrosine phosphatase Src homology 2 domain-containing phosphatase 2 in head and neck squamous cell carcinoma.
    Li Y; Guo Y; Liu Z; Mou Y; Fang H; Yang Y; Zhao X; Zhang H; Song X
    Arch Oral Biol; 2023 Mar; 147():105615. PubMed ID: 36630765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA human leucocyte antigen complex group-18 HCG18 (HCG18) promoted cell proliferation and migration in head and neck squamous cell carcinoma through cyclin D1-WNT pathway.
    Mao B; Wang F; Zhang J; Li Q; Ying K
    Bioengineered; 2022 Apr; 13(4):9425-9434. PubMed ID: 35389764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation.
    Li R; Zhang L; Jia L; Duan Y; Li Y; Bao L; Sha N
    PLoS One; 2014; 9(6):e100893. PubMed ID: 24967732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
    Wu X; Cheng YL; Matthen M; Yoon A; Schwartz GK; Bala S; Taylor AM; Momen-Heravi F
    J Exp Clin Cancer Res; 2021 Feb; 40(1):70. PubMed ID: 33596979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
    Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of long non-coding RNA LINC00958 inhibits head and neck squamous cell carcinoma progression and AKT/mTOR signaling pathway by targeting miR-106a-5p.
    Yang YF; Feng L; Shi Q; Wang LW; Hou LZ; Wang R; Fang JG
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8408-8417. PubMed ID: 32894548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
    Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk SNP-mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway.
    Hou Y; Zhou M; Li Y; Tian T; Sun X; Chen M; Xu W; Lu M
    Mol Carcinog; 2022 Aug; 61(8):797-811. PubMed ID: 35687049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of long non-coding RNA prostate cancer-associated ncRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells.
    Qiao L; Liu X; Tang Y; Zhao Z; Zhang J; Liu H
    Mol Cell Biochem; 2018 Apr; 441(1-2):99-108. PubMed ID: 28884413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.
    Hu W; Zhao Y; Su L; Wu Z; Jiang W; Jiang X; Liu M
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34435652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.
    Liu S; Wang Y; Han Y; Xia W; Zhang L; Xu S; Ju H; Zhang X; Ren G; Liu L; Ye W; Zhang Z; Hu J
    Theranostics; 2020; 10(23):10589-10605. PubMed ID: 32929368
    [No Abstract]   [Full Text] [Related]  

  • 40. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
    Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.